EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The rationale of the current study is to explore the use of combination chemotherapy together
with antiretroviral agents in order to determine the efficacy and toxicity of this approach,
while also examining markers of virus replication and expression, and tumor cell
proliferation to gain understanding of the biological basis of this malignancy and to
identify predictors of response.